Motif Bio is a clinical stage biopharmaceutical company developing novel antibiotics to treat patients with serious and life-threatening infections caused by multi-drug resistant bacteria.Read More

Stock Quote

MTFB (ADS)$8.70 Stock is Up 0.80 (10.13%)
Today's Open$8.50
Previous Close$7.90
Data as of August 14, 2018 3:59 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.Learn More


Upcoming Events

Motif Bio at the 8th Annual Solebury Trout Hamptons CEO Roundtable
Thursday, August 16, 2018
Motif Bio at H.C. Wainwright 20th Annual Global Investment Conference
Thursday, September 6, 2018 10:25 a.m. ET
Learn More